Growing development and demand for high value biopharmaceuticals, vaccines and gene therapy products including increasingly complex global clinical trials face ever increasing regulatory and security requirements related to the integrity of the current global cold chain logistics model. This dynamic situation makes it very difficult to monitor, track and optimize biologics logistics, resulting in a lack end-to-end transparency which can create regulatory compliance issues and risks to patient safety.

To address the global challenges of the current Cold Chain logistics model, SAS' Cold Chain Integrity solution provides monitoring, tracking and optimizing capabilities to help companies harness the highly dimensional and complex nature of biologics logistics.

Maintaining the integrity and addressing the efficiency of cold chain management for biologic products and especially vaccines necessitates three key capabilities: